(a) whether the task of identifying ceiling packs of drugs and determining their ceiling prices is done by the same officer;
(b) if so, the number of additional ceiling packs identified by National Pharmaceutical Pricing Authority;
(c) whether the Ministry has announced non-ceiling packs of formulation for tablets and capsules;
(d) whether it is a fact that other dosage forms like liquids, injectable and ointments have not been covered therein;
(e) if so, the reasons therefor; and
(f) steps taken by the Government to remove such discriminations?